CDK2 and non-small cell lung carcinoma: In NSCLC studies, the absence of YTHDF1 prevents cell growth and xenograft development by controlling the translation efficiency of CDK2, CDK4 and cyclin D1, suggesting that YTHDF1 loss can inhibit NSCLC progression.138